We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002241:SZSEGoertek Inc. Analysis

Data as of 2026-03-17 - not real-time

CN¥25.24

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Goertek is trading at CNY 25.24, comfortably below its 20‑day (CNY 25.88), 50‑day (CNY 27.48) and 200‑day (CNY 27.77) moving averages, indicating a short‑term bearish bias. The price sits just above the calculated support of CNY 24.22 and well under the near‑term resistance of CNY 27.20, with a neutral RSI of 40 and a MACD histogram that has turned positive, suggesting a tentative bullish signal amid decreasing volume. Volatility remains high at roughly 30% over the past 30 days, yet the beta of 0.52 points to lower systematic risk compared with the broader market. Fundamentally, the company posted 4.4% revenue growth and maintains modest margins (gross 12%, operating 5%). Its trailing PE of 30 is below the industry average of 34, and the forward PE of 23.5 signals improving earnings expectations. The dividend yield of 1.59% with a 30% payout ratio appears sustainable, while the DCF‑derived fair value of CNY 7.84 suggests the market may be pricing in a premium, leaving an upside potential of about 36% to consensus analyst targets. Overall, Goertek blends a value‑oriented valuation with modest growth prospects and a stable dividend, but technical pressure and high short‑term volatility temper the near‑term outlook.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price below all major moving averages
  • Decreasing volume and high short‑term volatility
  • Support level near CNY 24.22 offering limited downside

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Valuation gap (PE below industry, upside ~36%)
  • Sustainable dividend yield of 1.59%
  • Forward earnings growth implied by lower forward PE

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Exposure to growing smart‑wearable and VR markets
  • Moderate leverage with debt‑to‑equity around 59%
  • Stable cash generation and dividend sustainability

Key Metrics & Analysis

Financial Health

Revenue Growth4.40%
Profit Margin2.92%
P/E Ratio30.0
ROE8.17%
ROA2.05%
Debt/Equity59.11
P/B Ratio2.5
Op. Cash FlowCN¥5.0B
Free Cash FlowCN¥1.7B
Industry P/E34.2

Technical Analysis

TrendBearish
RSI40.1
SupportCN¥24.22
ResistanceCN¥27.20
MA 20CN¥25.88
MA 50CN¥27.48
MA 200CN¥27.77
MACDBullish
VolumeDecreasing
Fear & Greed Index79.45

Valuation

Fair ValueCN¥7.84
Target PriceCN¥34.30
Upside/Downside35.90%
GradeOvervalued
TypeValue
Dividend Yield1.59%

Risk Assessment

Beta0.52
Volatility29.72%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.